Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other neoplasm 1

Conditions

Stomach Neoplasms 6Peritoneal Neoplasms 6Ovarian Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Gastric Adenocarcinoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Appendiceal Neoplasms 2Uterine Neoplasms 1Stomach Diseases 1Pseudomyxoma Peritonei 1Ovarian Epithelial Cancer Recurrent 1Locally Advanced Gastric Cancer 1Krukenberg Tumor 1HIPEC 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric Cancer Peritoneal Metastases 1Digestive System Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

apatinib 2Hyperthermic Intraperitoneal Chemotherapy 2Gastrectomy 2trastuzumab deruxtecan 1taxane 1sintilimab 1pembrolizumab 1durvalumab 1disitamab vedotin 1cabozantinib 1Taxes 1Tadalafil 1SHR-1701 1S 1 (combination) 1Platinum 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Indocyanine Green 1Immunotherapy, Adoptive 1Cytoreduction Surgical Procedures 1Cisplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastric Adenocarcinoma × Hyperthermic Intraperitoneal Chemotherapy × 1 year × Clear all
NCT07178808 2026-05-01

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Banner Health

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡